No abstract available
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Multicenter Study
MeSH terms
-
Adult
-
Aged
-
Amino Acid Substitution
-
Antineoplastic Agents / therapeutic use*
-
Drug-Related Side Effects and Adverse Reactions / epidemiology
-
Erlotinib Hydrochloride
-
Female
-
Humans
-
Janus Kinase 2 / genetics*
-
Male
-
Middle Aged
-
Phenylalanine / genetics
-
Polycythemia Vera / drug therapy*
-
Polycythemia Vera / epidemiology
-
Polycythemia Vera / genetics*
-
Quinazolines / therapeutic use*
-
Treatment Outcome
-
Valine / genetics
Substances
-
Antineoplastic Agents
-
Quinazolines
-
Phenylalanine
-
Erlotinib Hydrochloride
-
JAK2 protein, human
-
Janus Kinase 2
-
Valine